The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.
about
High risk of under-grading and -staging in prostate cancer patients eligible for active surveillanceCosts of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysisMulti-parametric magnetic resonance imaging as a management decision tool.Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?Risk factors for infection following prostate biopsy - a case control study.Transrectal-ultrasound prostatic biopsy preparation: rectal enema vs. mechanical bowel preparationEvolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.Applying precision medicine to the active surveillance of prostate cancer.Rate of Gleason 7 or higher prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferationMR-targeted TRUS prostate biopsy using local reference augmentation: initial experienceActive surveillance for prostate cancerAssociation between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy.Active surveillance for clinically localized prostate cancer--a systematic review.The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis.The emerging threat of multidrug-resistant Gram-negative bacteria in urology.Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate BiopsyRole of prostate magnetic resonance imaging in active surveillance.Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.Optimizing safety and accuracy of prostate biopsy.TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells.Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review.Prevention of infectious complications after prostate biopsy procedure.The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance.Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study.A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance.Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance?Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance.The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan.What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?Active surveillance for localized prostate cancer: an analysis of patient contacts and utilization of healthcare resources.The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy.A novel technique using three-dimensionally documented biopsy mapping allows precise re-visiting of prostate cancer foci with serial surveillance of cell cycle progression gene panel.Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies.[Value of perineal HistoScanning™ template-guided prostate biopsy].Editorial Comment to Prediagnostic prostate-specific antigen kinetics and the risk of biopsy progression in active surveillance patients.Biopsy Strategies in the Analysis of Urologic Neoplasia
P2860
Q28543205-C353F3AB-8D8A-42B0-8907-09EF6B8955F0Q31143305-4C75484E-347D-4036-AEE3-1EF0616E701CQ33890160-246462D0-652D-4721-8714-2868B5B34EF1Q35097300-B98C68DF-7477-4BCC-AC52-905BAD3D3F5BQ35877692-8360E59F-EE32-4A42-BC4F-1D8759E345E0Q35921548-2C7437EF-FE58-4AB4-8836-32713373F592Q36522791-94EA78FD-FF3D-45CD-B032-EDE933E6A9A9Q36592871-46FEFDED-F1E6-47DD-9A72-8731764D5FE6Q36679385-FE319823-8910-4A24-B3F3-5FCDE4795AACQ37030124-32215569-32E9-4D62-A256-A1AEB2EC4507Q37138594-F9300B2C-D23E-46D1-BC46-5B160F3AB827Q37191405-95B68207-FF3E-464F-9A17-32550832B116Q37676127-1CA1315C-0541-49B3-8B71-35592FD66051Q38194533-DEF8D67C-D1D6-449A-87B4-031E30C9CC98Q38211603-563D81B3-4F7C-46E3-88B1-E629AD67F945Q38406134-E945A712-8394-4EBE-B957-91740C5284E9Q38579512-4FB9ADD0-BC03-4E2A-8D51-AB4C4744A62BQ38586761-A4522F82-67FD-4F0D-9E5D-80F458C5EFDDQ38671172-EA59DA94-C14C-42C4-BCF0-37EE1BB74F1AQ38799782-4C2BAE5F-7A44-471E-A956-770E4DB2F00DQ38841864-556CD27C-63E9-4A10-9DC9-B625A1EB8297Q38892034-ADB0C904-C6B8-47FD-8658-BA7930D0AE82Q38948160-6B7C498B-42CB-49AA-9982-9668B2D99BDEQ39337754-6E6895FE-B2ED-40DF-8EDA-72B9D5613D78Q39356191-1C4DEC3E-0E0B-45FB-B92F-6FBCE06885F3Q39531223-6DCB9D77-B16F-4D6A-873C-D43E2ED4AE61Q40109539-14FD8BB0-4CC1-4D4C-9852-17D75157647EQ40115001-BD5B7ACE-1ABA-418A-82C2-283FA3FE8CECQ40467014-3079F61B-0D64-4E0C-B184-53FE4B864D9AQ40524464-9BC33AE1-94D7-4631-9D28-81CBC84F8EF4Q40884788-866AF834-2511-442F-BA75-DAC2A5950C0FQ41748914-D24BCA26-81EA-47B9-B4CC-889D04FA56B8Q42067660-35DD062D-8459-42C6-92DE-952AB3FD2AADQ44245825-80D97651-0D85-458C-B2B3-F5297ECE9F1AQ45940658-16107FE3-0BB7-4103-BBE9-DA442337DB1AQ46167678-8E338F5F-802E-4DDC-B01F-B0A2EF138909Q47608517-6D4642C4-9D0A-4C60-A11F-8C0C63AAAD1DQ53020348-9E5E4EEA-A7D9-4E4A-BF3C-9C460849B691Q53852286-EF05C523-435E-4431-B0D2-98FC88D3EE63Q57766033-91C6341D-E8D9-4CF7-AA3E-24E9AEB9F7B9
P2860
The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The impact of repeat biopsies ...... cancer on active surveillance.
@en
The impact of repeat biopsies ...... cancer on active surveillance.
@nl
type
label
The impact of repeat biopsies ...... cancer on active surveillance.
@en
The impact of repeat biopsies ...... cancer on active surveillance.
@nl
prefLabel
The impact of repeat biopsies ...... cancer on active surveillance.
@en
The impact of repeat biopsies ...... cancer on active surveillance.
@nl
P2093
P1476
The impact of repeat biopsies ...... cancer on active surveillance.
@en
P2093
Anna Giallo-Uvino
Behfar Ehdaie
James Eastham
Jennifer Livingston
Karim Touijer
Maryellen O'Sullivan
Massimiliano Spaliviero
Peter Scardino
Pramod Sogani
P304
P356
10.1016/J.JURO.2013.08.088
P407
P577
2013-09-07T00:00:00Z